MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
29.86
+1.43 (5.03%)
At close: Dec 12, 2025, 4:00 PM EST
29.28
-0.58 (-1.94%)
After-hours: Dec 12, 2025, 6:18 PM EST
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.34 billion as of December 12, 2025. Its market cap has increased by 102.33% in one year.
Market Cap
1.34B
Enterprise Value
949.73M
1-Year Change
102.33%
Ranking
Category
Stock Price
$29.86
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.34B, an increase of 163.07%. That is a compound annual growth rate of 117.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 1.34B | 117.70% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |